Peer Reviewed
Feature Article Cardiovascular medicine

Evolving therapies for atrial fibrillation: focus on embolic stroke

Rajeev Pathak, Rajiv Mahajan, Prashanthan Sanders
Abstract
Oral anticoagulants are the treatment of choice for the prevention of stroke related to atrial fibrillation. Novel anticoagulants are now available and should be considered in suitable patients.
Key Points
  • Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia.
  • Strokes associated with AF often cause substantial neurological disability and mortality.
  • Antithrombotic therapy is the mainstay for stroke prevention.
  • Until recently, warfarin was the only effective oral anticoagulant available.
  • Novel anticoagulants are safe and easy to use.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?